CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
Sehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, Beomseok Suh, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Korean J Intern Med. 2017;32(3):514-522.   Published online 2017 April 14    DOI: https://doi.org/10.3904/kjim.2015.299

Excel Download

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
The Korean Journal of Internal Medicine. 2017;32(3):514-522   Crossref logo
Link1 Link2

69: Pemetrexed in the treatment of non-small-cell lung cancer
Lung Cancer. 2015;87:S27   Crossref logo
Link1 Link2

KRAS mutation, KRAS–LCS6 polymorphism, and non-small cell lung cancer
Lung Cancer. 2010;69(1):51-53   Crossref logo
Link1 Link2

Prognostic value of the new tumor marker CYFRA 21-1 in non-small cell lung cancer
Lung Cancer. 1994;11:40   Crossref logo
Link1 Link2

Accelerated induction therapy and resection for poor prognostic stage III non-small cell lung cancer
Lung Cancer. 1996;14(1):177-178   Crossref logo
Link1 Link2

KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer
European Journal of Cancer. 2017;72:S180   Crossref logo
Link1 Link2

Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]
Lung Cancer. 2010;70(2):230   Crossref logo
Link1 Link2

Biologic and molecular prognostic factors-Impact on treatment of patients with non-small cell lung cancer
Lung Cancer. 1995;13(2):201   Crossref logo
Link1 Link2

The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer
Cancer Genetics. 2013;206(1-2):26-31   Crossref logo
Link1 Link2

Activity of pemetrexed (alimta), a new antifolate, against non-small cell lung cancer
Lung Cancer. 2002;38:3-7   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.